Please login to the form below
Just::
This page shows the latest Just:: news and features for those working in and with pharma, biotech and healthcare.
Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data
In the new Brazilian results, the vaccine was found to be just 50.4% effective at preventing symptomatic COVID-19 infections, only just meeting the World Health Organization's (WHO) recommendation
Latest news
-
AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
Earlier this month, Moderna’s COVID-19 vaccine was granted a swift approval from the EC, just a day after the jab received a positive opinion from the CHMP.
-
Moderna wins EU authorisation for COVID-19 vaccine
It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by
-
EMA recommends authorisation of Moderna’s COVID-19 vaccine
It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by
-
Pfizer introduces new logo in a ‘shift from commerce to science’
Pfizer is no longer in the business of just treating diseases – we're curing and preventing them,” said Albert Bourla, chairman and chief executive officer of Pfizer.
-
Pfizer/BioNTech to offer COVID-19 vaccine to placebo recipients
Soon after the UK approval, the US Food and Drug Administration (FDA) approved the vaccine for an emergency use authorisation (EUA) just over a week later on 11 December 2020.
More from news
Approximately 6 fully matching, plus 3,385 partially matching documents found.
Latest Intelligence
-
Three ways AI will change healthcare in the next decade
A new way of learning. Importantly, it is not just patients who will benefit from AI in the coming decade.
-
The Brexit clock is counting down and time is running out
These significant changes are just around the corner now. The impact on the life sciences sector will be keenly felt and employers should take action to ensure they are ready for
-
Treatment and prevention of cardiovascular disease
The omega-3 story has just started with EPA which has laid the foundations for the platform.
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
Examining three entirely different approaches to CAR-T therapy, it is possible to see just how much space there is for this exciting sector, therefore displaying the case for continued investment. ... cytokine molecules are inadvertently released, but
-
Unlocking the potential of precision medicine in oncology
To me, this means providing patients with the invaluable gift of more quality time: not just adding years to life, but also life to years.
More from intelligence
Approximately 2 fully matching, plus 664 partially matching documents found.
Latest appointments
-
New executive appointments at Synergy Vision
Before taking on the managing director position, Henderson (pictured right) worked as director of medical strategy at Synergy, having joined just over one year ago.
-
W2O taps Tom Richards as creative leader of 21GRAMS
Not just in ideas that break the norms of traditional advertising, but in craft. ... Work that doesn’t just compete with other brands, but anything fighting for the audience’s attention,” said Richards.
-
New faces at Lucid Group and ZPB Associates
She joins ZPB from HAVAS Just:: where she provided support and strategic direction for client’s PR requirements.
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications
akt health communications makes its first hire. Just eight months since launching, akt healthcare communications has welcomed its first hire.
-
BMS appoints new commercial leader, Davies joins Eisai and more
The move comes at a challenging time for BMS, as its blockbuster immunotherapy Opdivo has just been overtaken in global revenues by its arch-rival, Merck &Co's Keytruda.
More from appointments
Approximately 3 fully matching, plus 65 partially matching documents found.
Latest from PMHub
-
A Magical Future – A year on from the graduate scheme
Lucid’s third cohort of graduates have just started their eight weeks of training, and I don’t doubt they’re having the same feelings I did when I first joined.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
Rather than looking at the genetic makeup of just the 20, 000 genes known to cause disorders, the whole genome is analysed.
-
Lockdown 3: Why patients cannot afford another pause in pharma-sponsored support
Just like pharma, patient groups have played a vital role in the response to the COVID-19 pandemic.
-
The other side of ... gout
And so, unsurprisingly, she expects her treatment to help her do just that – control her condition, minimising the number of gout episodes and offering her a near-to-normal life with
-
Why Don't More People Want to Change the World?
We just love the chase as an end in itself. If you’re in the healthcare industry, there are always new ways of doing things, new things to create and communicate. ... We will never be done. But we might just get high trying.
More from PMHub
Approximately 0 fully matching, plus 609 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- PHE study finds people who have had COVID-19 can still transmit the virus
- New study identifies drugs that are safe to use in COVID-19 treatment
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
